Home
Scholarly Works
Patient-Reported Quality of Life (QoL) Following...
Conference

Patient-Reported Quality of Life (QoL) Following CTL019 Infusion in Adult Patients (pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Authors

Maziarz RT; Bishop MR; Tam CS; Borchmann P; Jaeger U; McGuirk JP; Waller EK; Jaglowski S; Andreadis C; Foley SR

Volume

130

Publisher

AMER SOC HEMATOLOGY

Publication Date

December 7, 2017

Name of conference

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

GA, Atlanta

Conference start date

December 9, 2017

Conference end date

December 12, 2017

Conference proceedings

BLOOD

ISSN

0006-4971

Contact the Experts team